Astrocytes from familial and sporadic ALS patients are toxic to motor neurons

Cited by (783)

Items 301–400 of 783

1. Astrocytes and Microglia as Potential Contributors to the Pathogenesis of C9orf72 Repeat Expansion-Associated FTLD and ALS
   Hannah Rostalski, Stina Leskelä, Nadine Huber, Kasper Katisko, Antti Cajanus, Eino Solje, Mikael Marttinen, Teemu Natunen, Anne Marja Remes, Mikko O. Hiltunen et al. · 2019 · Frontiers in Neuroscience
2. Properties of Glial Cell at the Neuromuscular Junction Are Incompatible with Synaptic Repair in the SOD1 G37R ALS Mouse Model
   Éric Martineau, Danielle Arbour, Joanne Vallée, Richard Robitaille · 2020 · Journal of Neuroscience
3. Neural and glial progenitor transplantation as a neuroprotective strategy for Amyotrophic Lateral Sclerosis (ALS)
   Amanda M. Haidet-Phillips, Nicholas John Maragakis · 2015 · Brain Research
4. Utility of transcranial magnetic stimulation in delineating amyotrophic lateral sclerosis pathophysiology
   Steve Vucic, Matthew C. Kiernan · 2013 · Handbook of clinical neurology
5. Neuroinflammation in amyotrophic lateral sclerosis: pathogenic insights and therapeutic implications
   Aicee Dawn Calma, Nathan Pavey, Parvathi Menon, Steve Vucic · 2024 · Current Opinion in Neurology
6. The interplay between metabolic homeostasis and neurodegeneration: insights into the neurometabolic nature of amyotrophic lateral sclerosis
   Shyuan Thieu Ngo, Frederik J. Steyn · 2015 · Cell Regeneration
7. Lysosomal and phagocytic activity is increased in astrocytes during disease progression in the SOD1 G93A mouse model of amyotrophic lateral sclerosis
   David J. Baker, Daniel J. Blackburn, Marcus Keatinge, Dilraj Singh Sokhi, Paulius Viskaitis, Paul Roy Heath, Laura Ferraiuolo, Janine Kirby, Pamela J. Shaw · 2015 · Frontiers in Cellular Neuroscience
8. Advances in stem cell therapy for amyotrophic lateral sclerosis
   Letizia Mazzini, Daniela Ferrari, Pavle R. Anđjus, Leonora Bużańska, Roberto M. Cantello, Fabiola De Marchi, Maurizio Gelati, Rashid A. Giniatullin, Joel Clinton Glover, Mariagrazia Grilli et al. · 2018 · Expert Opinion on Biological Therapy
9. Dopamine, vocalization, and astrocytes
   Ariana Z. Turk, Mahsa Lotfi Marchoubeh, Ingrid Fritsch, Gerald A. Maguire, Shahriar SheikhBahaei · 2021 · Brain and Language
10. Microglial overexpression of fALS-linked mutant SOD1 induces SOD1 processing impairment, activation and neurotoxicity and is counteracted by the autophagy inducer trehalose
    Francesca Massenzio, Emiliano Peña‐Altamira, Sabrina Petralla, Marco Virgili, Giampaolo Zuccheri, Andrea Miti, Elisabetta Polazzi, Ilaria Mengoni, Deborah Piffaretti, Barbara Monti · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
11. The Dual Nature of Onuf’s Nucleus: Neuroanatomical Features and Peculiarities, in Health and Disease
    Roberta Schellino, Marina Boido, Alessandro Vercelli · 2020 · Frontiers in Neuroanatomy
12. NRF2 as a therapeutic opportunity to impact in the molecular roadmap of ALS
    José Jiménez-Villegas, Laura Ferraiuolo, Richard J. Mead, Pamela J. Shaw, Antonio Cuadrado, Ana Isabel Rojo · 2021 · Free Radical Biology and Medicine
13. Glial TDP‐43 and TDP‐43 induced glial pathology, focus on neurodegenerative proteinopathy syndromes
    Katherine E. Prater, Caitlin S. Latimer, Suman Jayadev · 2021 · Glia
14. Neuroimmunometabolism: A New Pathological Nexus Underlying Neurodegenerative Disorders
    Swarup Mitra, Avijit Banik, Sumit Saurabh, Malabika Maulik, Shailesh Khatri · 2022 · Journal of Neuroscience
15. Neuroinflammation in Amyotrophic Lateral Sclerosis: Role of Redox (dys)Regulation
    Nadia D’Ambrosi, Mauro Cozzolino, Maria Teresa Carrı̀ · 2017 · Antioxidants and Redox Signaling
16. Multiple Roles of Transforming Growth Factor Beta in Amyotrophic Lateral Sclerosis
    M. Galbiati, V. Crippa, P. Rusmini, Riccardo Cristofani, Elio Messi, Margherita Piccolella, B. Tedesco, Veronica Ferrari, Elena Casarotto, Marta Chierichetti et al. · 2020 · International Journal of Molecular Sciences
17. Chitotriosidase, a biomarker of amyotrophic lateral sclerosis, accentuates neurodegeneration in spinal motor neurons through neuroinflammation
    Anu Mary Varghese, Mausam Ghosh, Savita Kumari Bhagat, Kandasamy Vijayalakshmi, Veeramani Preethish‐Kumar, Seena Vengalil, Chevula Pradeep-Chandra-Reddy, Saraswati Nashi, Kiran Polavarapu, Meenakshi Sharma et al. · 2020 · Journal of Neuroinflammation
18. Immune-mediated processes in neurodegeneration: where do we stand?
    Fakhoury, Marc · 2016 · Journal of Neurology
19. TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis
    Sarah Lépine, María José Castellanos‐Montiel, Thomas M. Durcan · 2022 · Translational Neurodegeneration
20. Role of Oxidative Stress on the Etiology and Pathophysiology of Amyotrophic Lateral Sclerosis (ALS) and Its Relation with the Enteric Nervous System
    Laura López‐Pingarrón, Henrique Almeida, Marisol Soria-Aznar, Marcos César Reyes-Gonzales, María Pilar Terrón, Joaquín J. García · 2023 · Current Issues in Molecular Biology
21. Regulation of cortical hyperexcitability in amyotrophic lateral sclerosis: focusing on glial mechanisms
    Manling Xie, Praveen N. Pallegar, Sebastian Parusel, Aivi T. Nguyen, Long‐Jun Wu · 2023 · Molecular Neurodegeneration
22. The ER proteostasis network in ALS: Determining the differential motoneuron vulnerability
    Pablo Rozas, Leslie Bargsted, Francisca Martínez, Claudio A. Hetz, Danilo B. Medinas · 2016 · Neuroscience Letters
23. Species differences in immune‐mediated CNS tissue injury and repair: A (neuro)inflammatory topic
    Luke M. Healy, Moein Yaqubi, Samuel K. Ludwin, Jack Perry Antel · 2019 · Glia
24. Tumor Necrosis Factor Alpha in Amyotrophic Lateral Sclerosis: Friend or Foe?
    Giulia Guidotti, Chiara Scarlata, Liliana Brambilla, Daniela Rossi · 2021 · Cells
25. Elevated levels of IFNγ and LIGHT in the spinal cord of patients with sporadic amyotrophic lateral sclerosis
    Julianne Aebischer, Anice Moumen, Véronique Sazdovitch, Danielle Seilhean, Vincent Meininger, Cédric Raoul · 2012 · European Journal of Neurology
26. The potential of induced pluripotent stem cells as a translational model for neurotoxicological risk
    Kevin K. Kumar, Asad A. Aboud, Aaron B. Bowman · 2012 · NeuroToxicology
27. Group I metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis
    Francesco Giribaldi, Marco Milanese, Tiziana Bonifacino, Pia Irene Anna Rossi, Silvia Di Prisco, Anna Pittaluga, Carlo Tacchetti, Aldamaria Puliti, Cesare Usai, Giambattista Bonanno · 2012 · Neuropharmacology
28. MicroRNAs: Newcomers into the ALS Picture
    Cinzia Volonté, Savina Apolloni, Chiara Parisi · 2015 · CNS & Neurological Disorders - Drug Targets
29. Lack of TNF‐alpha receptor type 2 protects motor neurons in a cellular model of amyotrophic lateral sclerosis and in mutant SOD1 mice but does not affect disease progression
    Massimo Tortarolo, Antonio Vallarola, Dario Lidonnici, Elisa Battaglia, Francesco Gensano, Gabriella Spaltro, Fabio Fiordaliso, Alessandro Corbelli, Stefano Garetto, Elisa Martini et al. · 2015 · Journal of Neurochemistry
30. Serum levels of glial fibrillary acidic protein in patients with amyotrophic lateral sclerosis
    Federico Verde, Ilaria Milone, Alessio Maranzano, Eleonora Colombo, Silvia Torre, Federica Solca, Alberto Doretti, Francesco Gentile, Arianna Manini, Ruggero Bonetti et al. · 2022 · Annals of Clinical and Translational Neurology
31. Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases
    Natalie L. Payne, Aude Sylvain, Carmel O’Brien, Daniella Herszfeld, Guizhi Sun, Claude C.A. Bernard · 2014 · New Biotechnology
32. Use of biomarkers in ALS drug development and clinical trials
    Nadine Bakkar, Ashley V. Boehringer, Robert P. Bowser · 2014 · Brain Research
33. Death receptor 6 (DR6) antagonist antibody is neuroprotective in the mouse SOD1G93A model of amyotrophic lateral sclerosis
    Guanrong Huang, X Lee, Yuting Bian, Zhaohui Shao, G.-N. Sheng, R. Blake Pepinsky, Sha Mi · 2013 · Cell Death and Disease
34. Treatment with an antibody directed against Nogo-A delays disease progression in the SOD1G93A mouse model of Amyotrophic lateral sclerosis
    Virginie Bros‐Facer, David Krull, Adam R. Taylor, J. R. T. Dick, Stewart Bates, M. S. Cleveland, Rabinder K. Prinjha, Linda Greensmith · 2014 · Human Molecular Genetics
35. Astrocytes conspire with neurons during progression of neurological disease
    James C. McGann, Daniel T. Lioy, Gail Mandel · 2012 · Current Opinion in Neurobiology
36. Stem Cells in the Nervous System
    Angel R. Maldonado‐Soto, Derek H. Oakley, Hynek Wichterle, Joel M. Stein, Fiona K. Doetsch, Christopher E. Henderson · 2014 · American Journal of Physical Medicine & Rehabilitation
37. Concise Review: The Cellular Conspiracy of Amyotrophic Lateral Sclerosis
    Andrea Serio, Rickie Patani · 2017 · Stem Cells
38. Molecular Mechanisms in Amyotrophic Lateral Sclerosis: The Role of Angiogenin, a Secreted RNase
    Isabela M. Aparicio, Jochen H.M. Prehn · 2012 · Frontiers in Neuroscience
39. The Multifaceted Neurotoxicity of Astrocytes in Ageing and Age-Related Neurodegenerative Diseases: A Translational Perspective
    David S. Bouvier, Sonja Fixemer, Tony Heurtaux, Félicia Jeannelle, Katrin B. M. Frauenknecht, Michel Guy André Mittelbronn · 2022 · Frontiers in Physiology
40. The Inflammatory Puzzle: Piecing together the Links between Neuroinflammation and Amyotrophic Lateral Sclerosis
    Di He, Yan Chun Xu, Mingsheng Liu, Liying Cui · 2023 · Aging and Disease
41. A Human‐Based Functional NMJ System for Personalized ALS Modeling and Drug Testing
    Xiufang Guo, Virginia Smith, Max Jackson, My Tran, Michael Thomas, Aakash Patel, Eric LoRusso, Siddharth Nimbalkar, Yunqing Cai, Christopher W. McAleer et al. · 2020 · Advanced Therapeutics
42. Porphyromonas gingivalis: a potential trigger of neurodegenerative disease
    Ziyan Huang, Miao Hao, Naixu Shi, Xinyu Wang, Yuan Lin, Haotian Yuan, Xiaofeng Wang · 2025 · Frontiers in Immunology
43. The Astrocytic S100B Protein with Its Receptor RAGE Is Aberrantly Expressed in SOD1G93A Models, and Its Inhibition Decreases the Expression of Proinflammatory Genes
    Alessia Serrano, Claudia Donno, Stefano Giannetti, Mina Perić, Pavle R. Anđjus, Nadia D’Ambrosi, Fabrizio Michetti · 2017 · Mediators of Inflammation
44. Mitochondrial Modulation by Dichloroacetate Reduces Toxicity of Aberrant Glial Cells and Gliosis in the SOD1G93A Rat Model of Amyotrophic Lateral Sclerosis
    Laura Martínez Palma, Ernesto Miquel, Valentina Lagos-Rodríguez, Luis Barbeito, Adriana Cassina, Patricia Cassina · 2018 · Neurotherapeutics
45. Mutations in Superoxide Dismutase 1 (Sod1) Linked to Familial Amyotrophic Lateral Sclerosis Can Disrupt High-Affinity Zinc-Binding Promoted by the Copper Chaperone for Sod1 (Ccs)
    Stefanie D. Boyd, Morgan S. Ullrich, Jenifer S. Calvo, Fatemeh Behnia, Gabriele Meloni, Duane David Winkler · 2020 · Molecules
46. Therapeutic Potential of Astrocyte Transplantation
    Nataly Hastings, Wei‐Li Kuan, Andrew Osborne, Mark Kotter · 2022 · Cell Transplantation
47. Astrocytes: The Stars in Neurodegeneration?
    Katarina Stoklund Dittlau, Kristine Freude · 2024 · Biomolecules
48. The ALS-inducing factors, TDP43A315T and SOD1G93A, directly affect and sensitize sensory neurons to stress
    Sydney V. Doss, Natalia M. Sutherland, Sihui Zhang, Theo Hatzipetros, Fernando G. Vieira, Gregorio Valdez · 2018 · Scientific Reports
49. FM19G11-Loaded Gold Nanoparticles Enhance the Proliferation and Self-Renewal of Ependymal Stem Progenitor Cells Derived from ALS Mice
    Stefania Marcuzzo, Davide Isaia, Silvia Bonanno, Claudia Malacarne, Paola Cavalcante, Antonella Zacheo, Valentino Laquintana, Nunzio Denora, Barbara Sanavio, Elisa Salvati et al. · 2019 · Cells
50. Diphenyl diselenide protects motor neurons through inhibition of microglia-mediated inflammatory injury in amyotrophic lateral sclerosis
    Chun‐Ting Zhang, Hongyong Wang, Weiwei Liang, Yueqing Yang, Chaohua Cong, Ying Wang, Shuyu Wang, Xudong Wang, Di Wang, Di Huo et al. · 2021 · Pharmacological Research
51. Regenerative cellular therapies for neurologic diseases
    Michael Levy, Nicholas M. Boulis, Mahendra S. Rao, Clive Niels Svendsen · 2015 · Brain Research
52. The ‘Omics’ of Amyotrophic Lateral Sclerosis
    Diana Elia Caballero-Hernández, Miguel G. Toscano, Marta Cejudo‐Guillén, Maria Luisa García‐Martín, Soledad Lopez, Jaime M. Franco, Francisco Javier Quintana, Cintia Roodveldt, David Pozo · 2015 · Trends in Molecular Medicine
53. Single-cell transcriptomic and functional studies identify glial state changes and a role for inflammatory RIPK1 signaling in ALS pathogenesis
    Matija Zelic, Anna S. Blazier, Fabrizio Pontarelli, Michael J. LaMorte, Jeremy Huang, Ozge E. Tasdemir-Yilmaz, Yi Ren, Sean K. Ryan, Cynthia Shapiro, Caroline Morel et al. · 2025 · Immunity
54. Hu Antigen R (HuR) Is a Positive Regulator of the RNA-binding Proteins TDP-43 and FUS/TLS
    Liang Lu, Lei Zheng, Ying Si, Wenyi Luo, Gwendal Dujardin, Thaddaeus Kwan, Nicholas R. Potochick, Sunnie R. Thompson, David Alan Schneider, Peter H. King · 2014 · Journal of Biological Chemistry
55. Glia–neuron interactions in neurological diseases: Testing non-cell autonomy in a dish
    Kathrin Meyer, Brian K. Kaspar · 2016 · Brain Research
56. SMN deficiency does not induce oxidative stress in SMA iPSC-derived astrocytes or motor neurons
    Teresa N. Patitucci, Allison D. Ebert · 2015 · Human Molecular Genetics
57. Expression profile of pattern recognition receptors in skeletal muscle of SOD1 (G93A) amyotrophic lateral sclerosis (ALS) mice and sporadic ALS patients
    Swen Lehmann, E. Esch, P. Hartmann, Anand Goswami, Stefan Nikolin, Joachim Weis, Cordian Beyer, Sonja Johann · 2018 · Neuropathology and Applied Neurobiology
58. Glucagon-like peptide 1 receptor activation: anti-inflammatory effects in the brain
    Yolanda Diz-Chaves, Zainab Mastoor, Carlos Spuch, José Antonio Lamas, Lucas C. González-Matías, Federico Mallo · 2023 · Neural Regeneration Research
59. Altered astrocytic response to activation in SOD1G93A mice and its implications on amyotrophic lateral sclerosis pathogenesis
    Chen Benkler, Tali Ben‐Zur, Yael Barhum, Daniel Offen · 2012 · Glia
60. Altered miRNA expression is associated with neuronal fate in G93A-SOD1 ependymal stem progenitor cells
    Stefania Marcuzzo, Dimos Kapetis, Renato Mantegazza, Fulvio Baggi, Silvia Bonanno, Claudia Barzago, Paola Cavalcante, Nicole Kerlero de Rosbo, Pia Bernasconi · 2013 · Experimental Neurology
61. Genetic validation of a therapeutic target in a mouse model of ALS
    A. Sophie de Boer, Kathryn Koszka, Evangelos Kiskinis, Naoki Suzuki, Brandi N. Davis‐Dusenbery, Kevin C. Eggan · 2014 · Science Translational Medicine
62. Emerging Evidence Highlighting the Importance of Redox Dysregulation in the Pathogenesis of Amyotrophic Lateral Sclerosis (ALS)
    Cyril Jones Jagaraj, Sonam Parakh, Julie D. Atkin · 2021 · Frontiers in Cellular Neuroscience
63. Molecular Mechanisms of Cellular Senescence in Neurodegenerative Diseases
    Lee, He-Jin, Yoon, Ye-Seul, Lee, Seung-Jae · 2023 · Journal of Molecular Biology
64. Lipid nanoparticles and transcranial focused ultrasound enhance the delivery of SOD1 antisense oligonucleotides to the murine brain for ALS therapy
    Gayathri R. Ediriweera, Amal J. Sivaram, Gary Cowin, Mikayla L. Brown, Luke McAlary, Jeremy Stephen Lum, Nicholas L. Fletcher, Liam Robinson, Joshua D. Simpson, Liyu Chen et al. · 2024 · Journal of Controlled Release
65. Efficient and rapid conversion of human astrocytes and ALS mouse model spinal cord astrocytes into motor neuron-like cells by defined small molecules
    Andong Zhao, Hua Qin, Mengli Sun, Kui Ma, Xiaobing Fu · 2020 · Military Medical Research
66. Expression of Taurine Transporter (TauT) is Modulated by Heat Shock Factor 1 (HSF1) in Motor Neurons of ALS
    Min-Kyung Jung, Ki-Yoon Kim, Na-Young Lee, Young Sook Kang, Yu Jin Hwang, Yunha Kim, Jung‐Joon Sung, Ann Carolyn McKee, Neil W. Kowall, Jung-Hee Lee et al. · 2012 · Molecular Neurobiology
67. Human Pluripotent Stem Cells: Applications and Challenges in Neurological Diseases
    Youssef Hibaoui, Anis Féki · 2012 · Frontiers in Physiology
68. Altered mechanisms underlying the abnormal glutamate release in amyotrophic lateral sclerosis at a pre-symptomatic stage of the disease
    Tiziana Bonifacino, Laura Musazzi, Marco Milanese, Mara Seguini, Antonella Marte, Elena Gallia, Luca Cattaneo, Franco Onofri, Maurizio Popoli, Giambattista Bonanno · 2016 · Neurobiology of Disease
69. The Role of Neuroinflammation in Neurodegenerative Disorders
    Jessika Suescun, Shivika Chandra, Mya Caryn Schiess · 2018 · Elsevier eBooks
70. Dysregulation of IGF-1/GLP-1 signaling in the progression of ALS: potential target activators and influences on neurological dysfunctions
    Ambika Shandilya, Sidharth Mehan · 2021 · Neurological Sciences
71. Breached Barriers: A Scoping Review of Blood-Central Nervous System Barrier Pathology in Amyotrophic Lateral Sclerosis
    Ario Mirian, Alexander Joseph Moszczynski, Serena Soleimani, Isabelle Aubert, Lorne H. Zinman, Agessandro Abrahão · 2022 · Frontiers in Cellular Neuroscience
72. Significance of aberrant glial cell phenotypes in pathophysiology of amyotrophic lateral sclerosis
    Emiliano Trías, Sofía Ibarburu, Romina Barreto‐Núñez, Luis Barbeito · 2016 · Neuroscience Letters
73. Intercellular Signalling Cross-Talk: To Kill, To Heal and To Rejuvenate
    Egor Y. Plotnikov, Denis N. Silachev, Vasily A. Popkov, Ljubava D. Zorova, Irina B. Pevzner, Savva D. Zorov, Stanislovas S. Jankauskas, Valentina A. Babenko, Gennady Tikhonovich Sukhikh, Dmitry B. Zorov · 2017 · Heart Lung and Circulation
74. Genome-Scale Mapping of MicroRNA Signatures in Human Embryonic Stem Cell Neurogenesis
    Xuejun H. Parsons, James F. Parsons, Dennis A. Moore · 2012 · Molecular Medicine & Therapeutics
75. Pluripotent stem cell-based models of spinal muscular atrophy
    Emanuele Frattini, Margherita Ruggieri, Sabrina Salani, Irene Faravelli, Chiara Zanetta, Monica Nizzardo, Chiara Simone, Francesca Magri, Stefania Paola Corti · 2014 · Molecular and Cellular Neuroscience
76. Amyotrophic lateral sclerosis: Is the spinal fluid pathway involved in seeding and spread?
    Richard Alan Smith, Kathleen J. Myers, John Ravits, Robert P. Bowser · 2015 · Medical Hypotheses
77. Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype
    Monica Nizzardo, C. Simoné, Federica Rizzo, Gianna Ulzi, Agnese Ramirez, Mafalda Rizzuti, Andreina Bordoni, Monica Bucchia, Stefano Gatti, Nereo Bresolin et al. · 2016 · Scientific Reports
78. Additive amelioration of ALS by co‐targeting independent pathogenic mechanisms
    Ashley E. Frakes, Lyndsey Braun, Laura Ferraiuolo, Denis C. Guttridge, Brian K. Kaspar · 2017 · Annals of Clinical and Translational Neurology
79. Protocatechuic Acid Extends Survival, Improves Motor Function, Diminishes Gliosis, and Sustains Neuromuscular Junctions in the hSOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis
    Lilia A. Koza, Aimee N. Winter, Jessica Holsopple, Angela N. Baybayon-Grandgeorge, Claudia Peña, Jeffrey R. Olson, Randall C. Mazzarino, David Patterson, Daniel A. Linseman · 2020 · Nutrients
80. Mast Cell and Astrocyte Hemichannels and Their Role in Alzheimer’s Disease, ALS, and Harmful Stress Conditions
    Paloma A. Harcha, Polett Garcés, Cristián Arredondo, Germán R. Fernández, Juan Carlos Sáez, Brigitte van Zundert · 2021 · International Journal of Molecular Sciences
81. Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1G93A murine model of amyotrophic lateral sclerosis in a sex-dependent manner
    MacLean, Michael, Juranek, Judyta, Cuddapah, Swetha, López-Díez, Raquel, Ruiz, Henry H., Hu, Jiyuan, Frye, Laura, Li, Huilin, Gugger, Paul F., Schmidt, Ann Marie · 2021 · Journal of Neuroinflammation
82. Molecular hallmarks of ageing in amyotrophic lateral sclerosis
    Cyril Jones Jagaraj, Sina Shadfar, Sara Assar Kashani, Sayanthooran Saravanabavan, Fabiha Farzana, Julie D. Atkin · 2024 · Cellular and Molecular Life Sciences
83. Generation of GFAP::GFP astrocyte reporter lines from human adult fibroblast‐derived i PS cells using zinc‐finger nuclease technology
    Ping-Wu Zhang, Amanda M. Haidet-Phillips, Jacqueline T. Pham, Youngjin Lee, Yuqing Huo, Pentti J. Tienari, Nicholas John Maragakis, Rita Sattler, Jeffrey D. Rothstein · 2015 · Glia
84. Transplantation of mesenchymal stem cells in ALS
    Letizia Mazzini, Alessandro Vercelli, Ivana Ferrero, Marina Boido, Roberto M. Cantello, Franca Fagioli · 2012 · Progress in brain research
85. Systems-Wide Approaches in Induced Pluripotent Stem Cell Models
    Edward Lau, David T. Paik, Joseph C. Wu · 2018 · Annual Review of Pathology Mechanisms of Disease
86. Advances, Challenges, and Perspectives in Translational Stem Cell Therapy for Amyotrophic Lateral Sclerosis
    Elena Abati, Nereo Bresolin, Giacomo P. Comi, Stefania Paola Corti · 2019 · Molecular Neurobiology
87. Altered glucose catabolism in the presynaptic and perisynaptic compartments of SOD1G93A mouse spinal cord and motor cortex indicates that mitochondria are the site of bioenergetic imbalance in ALS
    Silvia Ravera, Carola Torazza, Tiziana Bonifacino, Francesca Provenzano, Claudia Rebosio, Marco Milanese, Cesare Usai, Isabella Panfoli, Giambattista Bonanno · 2019 · Journal of Neurochemistry
88. Circuit Mechanisms of Neurodegenerative Diseases: A New Frontier With Miniature Fluorescence Microscopy
    Craig T. Werner, Christopher J. Williams, Mercedes R. Fermelia, Da‐Ting Lin, Yun Li · 2019 · Frontiers in Neuroscience
89. STAT3 Modulation to Enhance Motor Neuron Differentiation in Human Neural Stem Cells
    Rajalaxmi Natarajan, Vinamrata Singal, Richard Benes, Junling Gao, Hoi C. Chan, Haijun Chen, Yongjia Yu, Jia Zhou, Ping Wu · 2014 · PLoS ONE
90. Perspective on SOD1 mediated toxicity in Amyotrophic Lateral Sclerosis
    Smriti Sangwan, David S Eisenberg · 2016 · Postępy Biochemii
91. Astrocyte-derived Jagged-1 mitigates deleterious Notch signaling in amyotrophic lateral sclerosis
    Annelies Nonneman, Nathan Criem, Sebastian A. Lewandowski, Rik Nuyts, Dietmar Rudolf Thal, Frank W. Pfrieger, John Ravits, Philip Van Damme, An Zwijsen, Ludo Van Den Bosch et al. · 2018 · Neurobiology of Disease
92. Thrombin and the Coag-Inflammatory Nexus in Neurotrauma, ALS, and Other Neurodegenerative Disorders
    Barry W. Festoff, Bruce A. Citron · 2019 · Frontiers in Neurology
93. Reactive astrocytes in ALS display diminished intron retention
    Oliver Jonathan Ziff, Doaa M Taha, Hamish Crerar, Benjamin E. Clarke, Anob M. Chakrabarti, Gavin P. Kelly, Jacob Neeves, Giulia E. Tyzack, Nicholas M. Luscombe, Rickie Patani · 2021 · Nucleic Acids Research
94. Neurotoxic Astrocytes Directly Converted from Sporadic and Familial ALS Patient Fibroblasts Reveal Signature Diversities and miR-146a Theragnostic Potential in Specific Subtypes
    Cátia Gomes, Catarina Sequeira, Shibi B. Likhite, Cassandra N. Dennys, Stephen J. Kolb, Pamela J. Shaw, Ana Rita Vaz, Brian K. Kaspar, Kathrin Meyer, Dora Maria Tuna Oliveira Brites · 2022 · Cells
95. Modeling amyotrophic lateral sclerosis in pure human iPSc-derived motor neurons isolated by a novel FACS double selection technique
    Diana Toli, Dorothée Buttigieg, Stéphane Blanchard, Thomas Lemonnier, Boris Lamotte d’Incamps, Sarah Bellouze, Gilbert Baillat, Delphine Bohl, Georg Haase · 2015 · Neurobiology of Disease
96. PGC-1α: a master gene that is hard to master
    Dan Lindholm, Ove Eriksson, Johanna Mäkelä, Natale Belluardo, Laura Korhonen · 2012 · Cellular and Molecular Life Sciences
97. Motor Neuron Death in ALS: Programmed by Astrocytes?
    Sheila K. Pirooznia, Valina Lynn Dawson, Ted M. Dawson · 2014 · Neuron
98. TDP-43—The key to understanding amyotrophic lateral sclerosis
    Zuoshang Xu, Chunxing Yang · 2014 · Rare Diseases
99. Current understanding of and emerging treatment options for spinal muscular atrophy with respiratory distress type 1 (SMARD1)
    Martina G. L. Perego, Noemi Galli, Monica Nizzardo, Alessandra Govoni, Michela Maria Taiana, Nereo Bresolin, Giacomo P. Comi, Stefania Paola Corti · 2020 · Cellular and Molecular Life Sciences
100. Necroptosis in CNS diseases: Focus on astrocytes
     Еlena V. Mitroshina, Mariia O. Saviuk, Maria V. Vedunova · 2023 · Frontiers in Aging Neuroscience